These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16299294)

  • 1. Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.
    Yager E; Bitsaktsis C; Nandi B; McBride JW; Winslow G
    Infect Immun; 2005 Dec; 73(12):8009-16. PubMed ID: 16299294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.
    Bitsaktsis C; Nandi B; Racine R; MacNamara KC; Winslow G
    Infect Immun; 2007 Oct; 75(10):4933-41. PubMed ID: 17664264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein.
    Nandi B; Hogle K; Vitko N; Winslow GM
    Infect Immun; 2007 Nov; 75(11):5453-9. PubMed ID: 17698576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis.
    Li JS; Yager E; Reilly M; Freeman C; Reddy GR; Reilly AA; Chu FK; Winslow GM
    J Immunol; 2001 Feb; 166(3):1855-62. PubMed ID: 11160232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis.
    Feng HM; Walker DH
    Infect Immun; 2004 Feb; 72(2):966-71. PubMed ID: 14742542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.
    Winslow GM; Yager E; Shilo K; Volk E; Reilly A; Chu FK
    Infect Immun; 2000 Apr; 68(4):2187-95. PubMed ID: 10722619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility and resistance to monocytic ehrlichiosis in the mouse.
    Winslow GM; Bitsaktsis C; Yager E
    Ann N Y Acad Sci; 2005 Dec; 1063():395-402. PubMed ID: 16481547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infection.
    Bitsaktsis C; Huntington J; Winslow G
    J Immunol; 2004 Jun; 172(11):6894-901. PubMed ID: 15153508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing protective immunity and immunopathology: a unifying model of monocytotropic ehrlichiosis.
    Ismail N; Walker DH
    Ann N Y Acad Sci; 2005 Dec; 1063():383-94. PubMed ID: 16481546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens.
    Habib S; El Andaloussi A; Hisham A; Ismail N
    PLoS One; 2016; 11(4):e0153223. PubMed ID: 27092553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of humoral immunity during Ehrlichia chaffeensis infection.
    Winslow GM; Yager E; Li JS
    Ann N Y Acad Sci; 2003 Jun; 990():435-43. PubMed ID: 12860671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells.
    Li JS; Winslow GM
    Infect Immun; 2003 Aug; 71(8):4229-37. PubMed ID: 12874298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization.
    Li JS; Chu F; Reilly A; Winslow GM
    J Immunol; 2002 Aug; 169(3):1419-25. PubMed ID: 12133967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection.
    Bitsaktsis C; Winslow G
    J Immunol; 2006 Oct; 177(7):4644-51. PubMed ID: 16982903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.
    Ismail N; Crossley EC; Stevenson HL; Walker DH
    Infect Immun; 2007 Sep; 75(9):4608-20. PubMed ID: 17562770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis of Genome of Ehrlichia sp. HF, a Model Bacterium to Study Fatal Human Ehrlichiosis.
    Lin M; Xiong Q; Chung M; Daugherty SC; Nagaraj S; Sengamalay N; Ott S; Godinez A; Tallon LJ; Sadzewicz L; Fraser C; Dunning Hotopp JC; Rikihisa Y
    BMC Genomics; 2021 Jan; 22(1):11. PubMed ID: 33407096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection.
    Stevenson HL; Jordan JM; Peerwani Z; Wang HQ; Walker DH; Ismail N
    Infect Immun; 2006 Aug; 74(8):4856-64. PubMed ID: 16861674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.
    Thirumalapura NR; Stevenson HL; Walker DH; Ismail N
    Infect Immun; 2008 May; 76(5):1920-30. PubMed ID: 18285501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis.
    Thirumalapura NR; Crocquet-Valdes PA; Saito TB; Thomas S; McBride JW; Walker DH
    Vaccine; 2013 Dec; 31(50):5960-7. PubMed ID: 24144475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model of fatal human monocytotropic ehrlichiosis.
    Sotomayor EA; Popov VL; Feng HM; Walker DH; Olano JP
    Am J Pathol; 2001 Feb; 158(2):757-69. PubMed ID: 11159213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.